Navigation Links
Verenium Reports Financial Results for the Third Quarter 2010
Date:11/9/2010

ry below, the historical results of the Company's cellulosic biofuels business for current and prior periods have been reclassified into discontinued operations as a result of the sale of the cellulosic biofuels business on September 2, 2010 to BP.

Revenues

Revenues for the periods ended September 30, 2010 and 2009 were as follows (in thousands): Three Months Ended 
September 30,Nine Months Ended 
September 30,2010200920102009Revenues:Animal Health and Nutrition

$
7,696$
7,919$
24,537$
23,846Grain Processing

3,3642,5249,6057,016All other products

1,1735832,9431,232Total product

12,23311,02637,08532,094Collaborative

3399031,3913,369Total revenues

$
2,572$
,929$
38,476$
35,463Total revenues for the nine months ended September 30, 2010 increased 8% to $38.5 million from $35.5 million for the same period in the prior year, with product revenues representing more than 90 percent of total revenues in both periods. Product revenues for the nine months ended September 30, 2010 increased 16% to $37.1 million from $32.1 million for same period in the prior year, primarily due to an increase in Phyzyme profit share from Danisco, as well as an increase in revenues from grain processing enzymes, Fuelzyme, Veretase and Xylathin, which continued to gain acceptance in the grain ethanol markets, and Purifine enzyme for the soybean oil processing market. Product revenue from non-Phyzyme products as a percentage of total product revenue increased to 34% for the nine months ended September 30, 2010 compared to 26% for the same period in the prior year.

Product Gross Profit

Product gross profit for the nine months ended September 30, 2010 increased to $13.9 million from $11.6 million for the same period in the prior year, primarily due to improved fixed cost leverage on higher revenue, partially offset by the imp
'/>"/>

SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Verenium to Present at Jefferies 10th Global Clean Technology Conference
2. Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement
3. Verenium Announces Regulatory Approval for Purifine® PLC in China
4. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
5. Verenium Appoints Kevin Bracken Vice President of Manufacturing
6. Verenium Announces Proposed Public Offering of Common Stock
7. Verenium 1:12 Reverse Stock Split Takes Effect
8. Verenium Announces Reverse Stock Split to Take Effect September 9
9. BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
10. Verenium Completes Amendment to 8% Senior Convertible Notes
11. Verenium Announces Organizational Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)...  Neurotech Pharmaceuticals, Inc., announced today the first ... 2 clinical trial of NT-503 Encapsulated Cell Therapy ... choroidal neovascularization secondary to age related macular degeneration ... growth factor (VEGF) receptor protein continuously produced by ... proof-of-concept study will evaluate NT-503 ECT as a ...
(Date:9/2/2015)... NESS ZIONA, Israel , September ... BVXV, TASE: BVXV) today announced the intent of the National ... U.S. National Institutes of Health (NIH) within the Department of ... 2 trial to be held in the United ... examine the use of BiondVax,s universal flu vaccine candidate, Multimeric-001 ...
(Date:9/2/2015)... San Diego, CA (PRWEB) , ... September 02, ... ... from troubleshooting faults in manufacturing equipment, to creating professional commercial video content, to ... beautifully detailed views of fascinating events that go by too quickly to process ...
(Date:9/1/2015)... , Sept. 1, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... 17 th Annual Global Investment Conference sponsored by ... 8-10, 2015 at The St. Regis Hotel in ... James Sapirstein , Chief Executive Officer, will provide ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... OmniGuide, Inc., the developer of the first and ... bandgap technology, today announced the results of a pre-clinical ... methods in neurosurgery. In the study, surgeons from the ... produced in live brain tissue with fiber delivered CO2 ...
... July 6 Ikaria Holdings, Inc. and BioLineRx Ltd. ... an agreement to obtain a worldwide exclusive license to ... cardiac remodeling following acute myocardial infarction (AMI). , ... is administered via the coronary artery during standard catheterization ...
... 6 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. ... distributor of nationally branded therapeutic, natural skin and health ... signed an agreement with 3PL Worldwide, Inc., for all ... Farley CEO explains that "3PL Worldwide offers true multichannel ...
Cached Biology Technology:New Pre-Clinical Data on OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting in Brain Tissue 2New Pre-Clinical Data on OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting in Brain Tissue 3IKARIA(R) to In-License BioLineRx's BL-1040 2IKARIA(R) to In-License BioLineRx's BL-1040 3avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaa's Product 2
(Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
(Date:8/10/2015)... and TELTOW, Germany , ... Instruments (SMI), a world leader in Eye Tracking ... completion of its OEM Eye Tracking Platform for integration ... Tracking Platform contains reference designs for seamless integration of ... systems, virtual reality HMDs and augmented reality smart glasses. ...
(Date:8/6/2015)... TELTOW, Germany , August 6, 2015 ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted ... this new solution, unprecedented quality and efficiency is brought ... context-sensitive displays. For the first time, professionals and researchers ...
Breaking Biology News(10 mins):HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... by Charles Darwin and confirmed that microbes can ... or trains - rather bacteria and fungi hitch-hike ... paper published in Environmental Microbiology, Dr. Anna Gorbushina ... of Geneva, Switzerland) and their colleagues analysed dust ...
... Launch Multi-agency Data Interoperability System, WALL, ... Bulletin Board: BKYI), a leader in finger-based ... its partner,DaProSystems today announced a contract award ... mobile data solution. Harrisonburg,s police,department has successfully ...
... Zucker Hillside Hospital campus of the Feinstein Institute for ... increase a persons risk for schizophrenia. In a study ... Academy of Sciences, the research team uncovered original evidence ... a recessive manner. A recessive trait is one that ...
Cached Biology News:Wireless Public Safety Solution From BIO-key(R) and DaProSystems Links Virginia Law Enforcement Agencies 2Wireless Public Safety Solution From BIO-key(R) and DaProSystems Links Virginia Law Enforcement Agencies 3Feinstein researchers develop new genetic method and identify novel genes for schizophrenia 2
Vitronectin Immunogen: Purified, full length, native human protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Guava has made microcapillary flow cytometry accessible ... experts alike will appreciate the latest addition ... Pluseasy to use, surprising affordable, and very ... system includes such features as absolute cell ...
...
Fingerprinting II Basic software is used for analyzing fingerprint sample types (electrophoretic gels, HPLC and other chromatographic patterns, spectrophotometric and densitometric curves)....
Biology Products: